Yahoo Web Search

  1. Yahoo Finance Results

  2. Is Teva Pharmaceutical Industries (TEVA) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers ...

  3. TEVA or AKRX: Which Is the Better Value Stock Right Now?

    Zacks via Yahoo FinanceJul 09 13:30 PM

    Generic Drugs stocks have likely encountered both Teva Pharmaceutical Industries Ltd. (TEVA) and Akorn (AKRX). We have found that the best way to discover ...

  4. Trump slams Pfizer after July 1 drug price hikes

    Reuters via Yahoo FinanceJul 09 23:49 PM

    NEW YORK/WASHINGTON (Reuters) - U.S. President Donald Trump on Monday took aim at Pfizer Inc and other U.S. drugmakers after they raised prices on some of their medicines on July 1, saying his ...

  5. 4 Warren Buffett Stocks to Buy in Q2 Earnings

    Zacks via Yahoo FinanceJul 13 12:49 PM

    It is not for no reason that Warren Edward Buffett is an investment guru. Suffice it to say that his company, Berkshire Hathaway Inc. BRK.B, has yielded a staggering return of more than 700% since inception.

  6. Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings

    Benzinga via Yahoo FinanceJul 12 14:28 PM

    The iShares Dow Jones US Healthcare (ETF) (NYSE: IYH) is up marginally year-to-date, but the profits aren’t bleeding into all health care constituents. Goldman Sachs analyst Jami Rubin upgraded ...

  7. The House of Representatives passed a package of opioid bills 396-14 on June 22. The final legislation will likely not make it to President Donald Trump's desk before the November midterm elections ...

  8. Insys Therapeutics Inc (NASDAQ: INSY) has a July 28 FDA date and is set to receive the verdict on the company's sublingual spray formulation of buprenorphine to treat moderate-to-severe acute ...

  9. ACADIA Pharmaceuticals Brings on Industry Vet as New Legal Boss

    ALM Media via Yahoo FinanceJul 20 16:30 PM

    ACADIA specializes in the development and commercialization of medicines to treat central nervous system disorders. Kim joins the company not long after the U.S. Food and Drug Administration ...

  10. Development) Arsanis Inc (NASDAQ: ASNS) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) Cytori Therapeutics Inc (NASDAQ: CYTX...

  11. Pfizer Inc. PFE and Eli Lilly and Company LLY announced that their NGF inhibitor, tanezumab, met all co-primary endpoints in a phase III study evaluating it in patients with osteoarthritis (“OA”) pain.

  1. Ad
    related to Teva Pharmaceutical Industries Ltd